Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC in Recurrent Ovarian Cancer: Randomized Trial on Survival
2012-002872-15Phase 3Completed
- Sponsor
- Policlinico Gemelli
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cisplatin in Ovarian Epithelial Adenocarcinoma (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Progression-free interval. Started Sep 2012; status: completed.
02
Drugs
cisplatin
03
Conditions
Ovarian Epithelial Adenocarcinoma
Beyond the preview
Go deeper on 2012-002872-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002872-15.